ExxPharma’s proprietary twin screw extrusion-based solubility enhancement technologies (DisExx™, SolExx™) are applicable to all poorly soluble drug substances irrespective of their physicochemical properties. Both technologies can integrate solubility enhancement with modified release or fixed dose combination products.
ExxPharma’s proprietary tamper-resistant, modified release technology platforms (OptExx™, ModExx™) generate robust dosage forms that are not susceptible to changes in release rate due to food effect or inadvertent tampering. The technologies provide products which exhibit a variety of release profiles.
Abuse deterrent Formulations
ExxPharma’s proprietary abuse deterrent technology platform (Sync-Loc™) utilizes a solvent-free continuous process to generate tamper-resistant products. The technology integrates mechanical, physical and chemical barriers to generate a synchronized abuse deterrent multi-barrier system that prevents dosage form tampering and abuse.
Each of ExxPharma’s proprietary technologies can be integrated with one another to provide value-added fixed dose combination products without compromising the benefits of each of the technologies. The same technologies are also applicable to high dose products, taste-masking and orally disintegrating/dispersible systems.